Test cartridge

Deaou Gene is dedicated to the development of molecular diagnostic reagents across multiple fields, including respiratory infections, sexual health, gastrointestinal diseases, and arboviruses. The current portfolio features assays for influenza viruses, RSV, SARS-CoV-2, Mycoplasma pneumoniae, Chlamydia pneumoniae, and Mycobacterium tuberculosis with drug-resistance mutations, delivering high sensitivity, strong specificity, and reliable stability. In addition, Deaou Gene is actively expanding its pipeline to address broader clinical needs. Upcoming assays include detection of carbapenem-resistance genes, methicillin-resistant Staphylococcus aureus (MRSA), lower respiratory tract infections, high-risk HPV genotypes, gastrointestinal pathogens, and multiple arboviruses. With a commitment to innovation and precision, Deaou Gene provides rapid and accurate diagnostic solutions to support effective clinical decision-making.